Cardiology
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
Latest News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.
Latest News
Higher omega-3 fatty acid levels cut heart failure risk
Article
Follow Where She Leads
This 75-year-old woman had been doing well in follow-up for aortic stenosis, but her recently increasing dyspnea has led her to the clinic. What...
Original Research
Enoxaparin vs Continuous Heparin for Periprocedural Bridging in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease
Bridging with enoxaparin rather than heparin has the potential to reduce the length of hospital stay, incidence of nosocomial infections, and cost...
News
Lipoprotein(a) levels tied to higher ischemic stroke risk
High levels of lipoprotein(a) [Lp(a)] and LPA genotypes were linked to increased ischemic stroke risk in a recent large, contemporary general...
News
Could some elderly skip statins based on negative risk markers?
News
No cardiovascular benefit from vitamin D supplementation
Here is yet more evidence that vitamin D doesn’t prevent heart disease.
News
Cognitive decline sped up after CHD
The acceleration in cognitive decline persisted for years after incident CHD.
Conference Coverage
Rivaroxaban tied to higher GI bleeding than other NOACs
SAN DIEGO – Real-world studies comparing the GI bleeding rates among different non–vitamin K anticoagulants have been limited.